Parnell Pharmaceuticals Holdings Ltd.PARN was a big mover last session, as the company saw its shares rise over 5% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock has risen about 29% in the past one-month time frame.
In the last 30 days, the company witnessed 1 downward estimate revision and the Zacks Consensus Estimate of a loss widened over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.
Parnell Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
An attractive player in the same industry includes Amphastar Pharmaceuticals, Inc. AMPH with a Zacks Rank #1 (Strong Buy).